Under Armour Beats with Less Than Expected Losses on Earnings Per Share

  a day ago at Macroaxis 
By Nathan Young

With as many clothing lines as there are, the competition is fierce. Not only in clothing, but accessories as well, with watches and other health indicators. This company is fairly new to the game, but they have been able to stand out among the rest and become one of the most recognizable names in athletic wear. With their recent numbers, they were able to cut losses which w... [more]

 fundamentals retail   under armour consumer sports equipment manufacturers and retailers consumer goods textile - apparel clothing

The company reported a loss in earnings per share, as expected, but not as severe as though. Earnings per share loss came in at 1 cent versus the expected loss of 4 cents. The revenue came in at $1.12 billion against the $1.11 billion that was expected. Another statistic point you look at is sales climbed about seven percent to $1.12 billion from $1.05 billion a year earlier. These are numbers that appears to be close to what everyone was expecting, but you have to look deep into the fundamentals to fully understand if the company is gong to continue to succeed.

Some of the risks that the company poses is first, the amount of competition in this space. If they begin to slow on production or their product quality begins to slip, it can certainly hurt sales and ultimately give up market share. Another risk to look at is whether or not that company can advertise in the major sporting venues and land brand deals. In the NFL it currently has a deal with Nike, and if the company could push into one of the major sports, it would certainly raise brand awareness. So the risk is lack of marketing could hurt the company in the long run.

   a minute ago at Macroaxis
Filed for Albert Bourla

Payment of 58 shares by Albert Bourla of Pfizer subject to Rule 16b3

Filed transaction by Pfizer Inc officer. Payment of exercise price or tax liability by delivering or withholding securities. Pfizer Inc insider trading alert for general transaction of common stock by Albert Bourla, Group President, on August 1, 2017. This event was filed by Pfizer Inc with SEC on 2017-03-01. Statement of changes in beneficial ownership - SEC Form 4. Albert Bourla is currently serves as group president - vaccines, oncology and consumer healthcare business of Pfizer Inc  
 general transaction pfizer   healthcare pharmaceuticals and biosciences pharmaceutical products
  few hours ago at Macroaxis
Filed for Mollie Hunter

Disposition of 40000 shares by Mollie Hunter of Accelrys subject to Rule 16b 3

Filed transaction by Accelrys Inc officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3. Accelrys Inc insider trading alert for disposition of stock option (right to buy) by Mollie Hunter, SVP GLOBAL SALES SERVICES, on April 28, 2017. This event was filed by Accelrys Inc with SEC on 2014-05-01. Statement of changes in beneficial ownership - SEC Form 4  
 disposition accelrys   business services
  few hours ago at Macroaxis
Filed for John Rutherford

Sale by John Rutherford of tradable shares of MedAssets

Filed transaction by Medassets Inc director. General open market or private sale of non-derivative or derivative security. MedAssets Inc insider trading alert for sale of common stock by John Rutherford, the corporate stakeholder, on April 28, 2017. This event was filed by Medassets Inc with SEC on 2010-04-28. Statement of changes in beneficial ownership - SEC Form 4  
 sale medassets   business services
  a day ago at Macroaxis
Filed for Sol Barer

Aevi Genomic exotic insider transaction detected

Filed transaction by Aevi Genomic Medicine Inc director. Unconventional Insider trading. Aevi Genomic Medicine Inc insider trading alert for general transaction of common stock by Sol Barer, the corporate stakeholder, on April 27, 2017. This event was filed by Aevi Genomic Medicine Inc with SEC on 2017-04-27. Statement of changes in beneficial ownership - SEC Form 4. Sol Barer is currently serves as non-executive chairman of the board of Aevi Genomic Medicine  
 general transaction aevi genomic   pharmaceutical products
  a day ago at Macroaxis
Filed for Mark Stoeckle

Adams Natural exotic insider transaction detected

Filed transaction by Adams Natural Resources F director. Unconventional Insider trading. Adams Natural Resources Fund Inc insider trading alert for general transaction of common stock by Mark Stoeckle, CEO, on April 27, 2017. This event was filed by Adams Natural Resources F with SEC on 2017-04-27. Statement of changes in beneficial ownership - SEC Form 4. Mark Stoeckle is currently serves as ceo, sr. portfolio manager, interested director, and member of executive committee of Adams Natural Resources  
 general transaction adams natural  
  a day ago at Macroaxis
Filed for John Briggs

Exercise or conversion by John Briggs of 1226 shares of Healthcare Services subject to Rule 16b 3

Filed transaction by Healthcare Services Group director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3. Healthcare Services Group Inc insider trading alert for exercise of stock option (right to buy) by John Briggs, the corporate stakeholder, on April 27, 2017. This event was filed by Healthcare Services Group with SEC on 2017-04-27. Statement of changes in beneficial ownership - SEC Form 4  
 exercise healthcare services   healthcare
  a day ago at Macroaxis
Filed for Robert Preti

Payment of 247 shares by Robert Preti of Caladrius Biosciences subject to Rule 16b 3

Filed transaction by Caladrius Biosciences Inc director. Payment of exercise price or tax liability by delivering or withholding securities. Caladrius Biosciences Inc insider trading alert for payment of common stock by Robert Preti, the corporate stakeholder, on April 27, 2017. This event was filed by Caladrius Biosciences Inc with SEC on 2017-04-27. Statement of changes in beneficial ownership - SEC Form 4. Robert Preti is currently serves as cto, sr. vp of manufacturing and technical operations and director of Caladrius Biosciences  
 payment caladrius biosciences   healthcare
  a day ago at Macroaxis
Filed for Michael Donovan

Exercise or conversion by Michael Donovan of 4580 shares of Hills Bancorp subject to Rule 16b 3

Filed transaction by Hills Bancorporation director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3. Hills Bancorp insider trading alert for exercise of stock options by Michael Donovan, the corporate stakeholder, on April 27, 2017. This event was filed by Hills Bancorporation with SEC on 2017-04-27. Statement of changes in beneficial ownership - SEC Form 4  
 exercise hills bancorp   banking financial regional - midwest banks
  a day ago at Macroaxis
Filed for Seifert Kathi P

Purchase by Seifert Kathi P of 1088 shares of County Bancorp

Filed transaction by County Bancorp Inc director. General open market or private purchase of non-derivative or derivative security. County Bancorp Inc insider trading alert for perchase of common stock by Seifert Kathi P, the corporate stakeholder, on April 27, 2017. This event was filed by County Bancorp Inc with SEC on 2017-04-27. Statement of changes in beneficial ownership - SEC Form 4  
 perchase county bancorp   banking financial savings and loans

Share Stories

Syndicate Stories to major social sites

Did you try this?

Run Content Syndication Now
   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
Hide  View All  Next  Launch Content Syndication
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Equity Screener
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
Research Equities
Insiders Screener
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders